In primary sclerosing cholangitis patients, a combination of abnormal CEA (>5.2 ng/mL) and CA 19-9 (>180 U/mL) have 100 % sensitivity to the diagnosis of bile duct malignancy [15], but this result was not suggested as a diagnostic criteria [16]. Here, CEACAM5 is linked to sclerosing cholangitis.